Cart
sales@molnova.com
JSF-4088
CAS No. ——
JSF-4088( JSF4088 )
Catalog No. M17104 CAS No. ——
JSF-4088 (JSF4088) is a novel antitubercular agent with potent in vitro antitubercular potency (MIC=19 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJSF-4088
-
NoteResearch use only, not for human use.
-
Brief DescriptionJSF-4088 (JSF4088) is a novel antitubercular agent with potent in vitro antitubercular potency (MIC=19 nM).
-
DescriptionJSF-4088 (JSF4088) is a novel antitubercular agent with potent in vitro antitubercular potency (MIC=19 nM), with no significant Vero cell cytotoxicity (CC50 >120 uM).
-
In Vitro——
-
In Vivo——
-
SynonymsJSF4088
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight410.426
-
Molecular FormulaC22H22N2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(2-(2-((2-methoxyphenoxy)methyl)phenyl)propan-2-yl)-5-nitrofuran-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gallardo-Macias R, et al. Bioorg Med Chem Lett. 2018 Dec 24. pii: S0960-894X(18)31001-1.
molnova catalog
related products
-
Irloxacin
Irloxacin is a new quinolone derivative, and shows greater activity with an acid pH. Irloxacin has a good in vitro antimicrobial spectrum against both gram-positive and gram-negative bacteria.
-
ANT431 sodium
ANT431 sodium is a novel, highly water-soluble metallo-β-lactamase (MBL) inhibitor with IC50 of 290 nM and 195 nM for NDM-1 and VIM-2.
-
Cyproconazole
Cyproconazole is a triazole fungicide. It is used agriculturally for protection of crops against a wide variety of fungal pathogens.Cyproconazole has been shown to cause a dose dependent inhibition of progesterone production in human placental cells in vitro.
